<code id='65BFAB1782'></code><style id='65BFAB1782'></style>
    • <acronym id='65BFAB1782'></acronym>
      <center id='65BFAB1782'><center id='65BFAB1782'><tfoot id='65BFAB1782'></tfoot></center><abbr id='65BFAB1782'><dir id='65BFAB1782'><tfoot id='65BFAB1782'></tfoot><noframes id='65BFAB1782'>

    • <optgroup id='65BFAB1782'><strike id='65BFAB1782'><sup id='65BFAB1782'></sup></strike><code id='65BFAB1782'></code></optgroup>
        1. <b id='65BFAB1782'><label id='65BFAB1782'><select id='65BFAB1782'><dt id='65BFAB1782'><span id='65BFAB1782'></span></dt></select></label></b><u id='65BFAB1782'></u>
          <i id='65BFAB1782'><strike id='65BFAB1782'><tt id='65BFAB1782'><pre id='65BFAB1782'></pre></tt></strike></i>

          focus

          focus

          author:hotspot    Page View:63
          Doctor sitting at a crowded desk. -- first opinion coverage from STAT
          Adobe

          SAN FRANCISCO — If you learned anything about nonprofit hospitals on the first day of the J.P. Morgan Healthcare Conference, it’s that they’ve all but abandoned the prospect of making significant profit on patient care. Instead, they’re fully throwing their weight into other ways of making money — things like developing drugs or selling insurance.

          Making money outside of patient care — or “revenue diversification,” if you prefer industry jargon — has always made appearances on hospital slides at the annual investor conference in San Francisco. This year, though, hospital executives are projecting a sense of urgency around growing profit in other areas to make up for losing money on their bread and butter: taking care of patients in hospitals.

          advertisement

          “It used to be nice to have, but now it’s a must-have, especially for not-for-profit health systems,” Niyum Gandhi, the chief financial officer of Boston’s Mass General Brigham said in an interview with STAT after his presentation.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          23andMe had bad news about my health. I wish a person had delivered it
          23andMe had bad news about my health. I wish a person had delivered it

          ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

          read more
          FDA approves RSV monoclonal antibody for infants, toddlers
          FDA approves RSV monoclonal antibody for infants, toddlers

          SanofiTheFoodandDrugAdministrationapprovedamonoclonalantibodytoprotectinfantsandyoungchildrenfromsev

          read more
          United colonoscopy coverage change 'may cost lives,' doctors say
          United colonoscopy coverage change 'may cost lives,' doctors say

          AdobeWhengastroenterologistslearnedinMarchthatUnitedHealthcareplanstobarricademanycolonoscopiesbehin

          read more

          EpiPen alternative approval delay highlights citizen petition issue

          AlexWong/GettyImagesAmericanswhosuffersevereallergicreactionswon’thavealternativestoauto-injectorsli